DeutschNewstral
Article
Ffnlondon.com on 2021-12-06 13:57
U.K. drugmaker to be taken public in €1.5 billion SPAC deal2 min read
Related news
Quanergy to Go Public Through SPAC Deal2 min readwsj.com- MCannabis banking firm Safe Harbor going public via SPAC deal2 min readmarketwatch.com
- BInvestment Firms Tiedemann, Alvarium to Merge, Go Public in SPAC Deal2 min readbarrons.com
- FBig Ten hopes to earn at least $1.5 billion annually in media rights deal2 min readfrontofficesports.com
- BU.K.'s Hg to Scoop Up Riskalyze in First U.S. Wealth-Tech Deal2 min readbarrons.com
- BU.S., U.K. Defense Stocks Will Benefit From Australian Submarine Deal2 min readbarrons.com
What is a SPAC?The Economist- MU.K. inflation drops to 1.5% in Marchmarketwatch.com
- MU.K. economy shrinks 1.5% in first quartermarketwatch.com
SPAC Attack! SPAC IPOs Are Boomingjdsupra.com- SPAC Transactions in Cannabis: What’s a SPACjdsupra.com
- UK to Adopt a New SPAC Listing Regime From 10 August 2021jdsupra.com
- BUBS to Buy Pioneering Robo-Advisor Wealthfront in $1.4 Billion Deal2 min readbarrons.com
- BPhilip Morris to Buy U.K. Drugmaker Vectura in $1.4 Billion Deal3 min readbarrons.com
UnitedHealth's Optum buys U.K.-based software company for $1.5 billionbizjournals.com
Weight-Loss Drug Wegovy Launches In U.K. As Shares Of Drugmaker Novo Nordisk Hit New PeakForbes
CPPIB acquires Liberty Living in U.K. for $1.5-billionThe Globe and Mail- Was it SPAC week? SEC charges SPAC with misleading statementsjdsupra.com
- European SPAC & De-SPAC Data & statistics roundup - December 2021jdsupra.com
Mylan raises bid for fellow drugmaker Perrigotriblive.com